Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
Yuji Okuyama,* Kazuto Oya,* Shinji Matsunaga, Taro Kishi, Nakao Iwata Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan *These authors contributed equally to this work Abstract: This study aimed to perform a comprehensive meta-analysis of topiramate-augmen&...
Guardado en:
Autores principales: | Okuyama Y, Oya K, Matsunaga S, Kishi T, Iwata N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb520151a6464b2a9c6e68e48718e36a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
por: Kishi T, et al.
Publicado: (2018) -
Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
por: Kishi T, et al.
Publicado: (2017) -
Is uveitis associated with topiramate use? A cumulative review
por: Goldberg JL, et al.
Publicado: (2016) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
por: Kishi T, et al.
Publicado: (2016) -
Topiramate add-on treatment associated with normalization of prolactin levels in a patient with schizophrenia
por: Huang Y, et al.
Publicado: (2017)